160
Participants
Start Date
May 28, 2024
Primary Completion Date
October 29, 2027
Study Completion Date
October 18, 2028
JNJ-88998377
JNJ-88998377 will be administered.
RECRUITING
National Taiwan University Hospital, Taipei
RECRUITING
Linkou Chang Gung Memorial Hospital, Taoyuan District
RECRUITING
Koc University Medical Faculty, Istanbul
RECRUITING
A O U Sant Orsola Malpighi, Bologna
RECRUITING
Beijing Cancer Hospital, Beijing
RECRUITING
Fudan University Shanghai Cancer Center, Shanghai
RECRUITING
Tianjin Medical University Cancer Institute and Hospital, Tianjin
RECRUITING
The First Affiliated Hospital Zhejiang University College of Medicine, Hangzhou
RECRUITING
Sun Yat Sen University Cancer Center, Guangzhou
COMPLETED
National Cancer Center Hospital, Chūōku
RECRUITING
National Cancer Center Hospital East, Kashiwa
RECRUITING
The Cancer Institute Hospital of JFCR, Tokyo
RECRUITING
Pratia Onkologia Katowice, Katowice
RECRUITING
Swietokrzyskie Centrum Onkologii SPZOZ w Kielcach, Klinika Hematologii i Transplantacji Szpiku, Kielce
RECRUITING
Aidport Sp z o o, Skorzewo
RECRUITING
Seoul National University Hospital, Seoul
RECRUITING
Samsung Medical Center, Seoul
RECRUITING
Dr Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara
RECRUITING
Ankara University Medical Faculty, Ankara
Janssen Research & Development, LLC
INDUSTRY